AAP
OM icon

Arax Advisory Partners’s Outset Medical OM Stock Holding History

Arax Advisory Partners’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.3K Buy
15,582
+15,460
+12,672% +$67.6K ﹤0.01% 3034
2026
Q1 		$468 Buy
+122
New +$500 ﹤0.01% 3423
2025
Q4 		– Sell
-1,239
Closed -$17.5K – 4407
2025
Q3 		$17.5K Buy
+1,239
New +$19.3K ﹤0.01% 2325

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Arax Advisory Partners's OM Position: Q2 2026 in Review

Arax Advisory Partners increased its Outset Medical (OM) stake by 12,672% in Q2 2026, buying an estimated $67.6K and bringing the position to 15,582 shares worth $67.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3034.

Arax Advisory Partners first reported a position in OM in Q3 2025 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Arax Advisory Partners held 15,582 shares of Outset Medical worth $67.3K as of Q2 2026.
  • Arax Advisory Partners bought 15,460 Outset Medical shares in Q2 2026, an estimated $67.6K.
  • Outset Medical made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3034 holding.
  • Arax Advisory Partners first reported a position in Outset Medical in Q3 2025 and has held it in 3 quarters since.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.